Benzinga's Top Upgrades, Downgrades For September 5, 2018

Top Upgrades

  • Morgan Stanley upgraded BP plc (ADR) BP from Equal-Weight to Overweight. BP shares fell 0.37 percent to close at $42.72 on Tuesday.
  • Barclays upgraded PerkinElmer, Inc. PKI from Underweight to Equal-Weight. PerkinElmer shares rose 0.03 percent to close at $92.46 on Tuesday.
  • Morgan Stanley upgraded Anthem Inc ANTM from Equal-Weight to Overweight. Anthem shares fell 0.39 percent to close at $263.70 on Tuesday.
  • Bernstein upgraded Vodafone Group Plc (ADR) VOD from Market Perform to Outperform. Vodafone shares fell 0.05 percent to $21.24 in pre-market trading.

 

Top Downgrades

  • Barclays downgraded Hologic, Inc. HOLX from Overweight to Equal-Weight. Hologic shares fell 0.10 percent to close at $39.72 on Tuesday.
  • Cowen & Co. downgraded K2M Group Holdings Inc KTWO from Outperform to Market Perform. K2M Group shares fell 0.11 percent to close at $27.31 on Tuesday.
  • BMO Capital downgraded CSX Corporation CSX from Outperform to Market Perform. CSX shares fell 1.48 percent to $73.73 in pre-market trading.
  • Macquarie downgraded Vail Resorts, Inc. MTN from Outperform to Neutral. Vail Resorts shares rose 1.13 percent to close at $301.42 on Tuesday.
  • Goldman Sachs downgraded Robert Half International Inc. RHI from Neutral to Sell. Robert Half shares fell 4.29 percent to $75.40 in pre-market trading.
  • Barclays downgraded Myriad Genetics, Inc. MYGN from Equal-Weight to Underweight. Myriad Genetics shares rose 1.10 percent to close at $50.34 on Tuesday.
  • BMO Capital downgraded Canadian National Railway (USA) CNI from Outperform to Market Perform. Canadian National Railway shares fell 1.68 percent to close at $87.42 on Tuesday.
  • Argus downgraded Tyson Foods, Inc. TSN from Buy to Hold. Tyson Foods shares fell 0.59 percent to $62.38 in pre-market trading.

 

Top Initiations

  • Raymond James initiated coverage on Xylem Inc XYL with an Outperform rating. The price target for Xylem is set to $90. Xylem shares closed at $75.66 on Tuesday.
  • Analysts at Barclays initiated coverage on Bio-Rad Laboratories, Inc. BIO with an Equal-Weight rating. The price target for Bio-Rad is set to $345. Bio-Rad Laboratories shares closed at $326.15 on Tuesday.
  • Mitsubishi UFJ initiated coverage on Usa Compression Partners LP USAC with an Overweight rating. The price target for Usa Compression Partners is set to $22. Usa Compression Partners shares closed at $16.66 on Tuesday.
  • Analysts at Imperial Capital initiated coverage on Mesa Air Group Inc MESA with an Outperform rating. The price target for Mesa Air is set to $18. Mesa Air shares closed at $15.82 on Tuesday.
  • Barclays initiated coverage on Amalgamated Bank AMAL with an Overweight rating. The price target for Amalgamated Bank is set to $20. Amalgamated Bank shares closed at $17.75 on Tuesday.
  • Stephens & Co. initiated Carvana Co CVNA with an Equal-Weight rating. Carvana shares closed at $67.34 on Tuesday.
  • Wedbush initiated coverage on Liquidia Technologies LQDA with an Outperform rating. The price target for Liquidia Technologies is set to $26. Liquidia Technologies shares closed at $17.39 on Tuesday.
  • Deutsche Bank initiated coverage on Caesars Entertainment Corporation CZR with a Buy rating. The price target for Caesars Entertainment is set to $14. Caesars Entertainment shares closed at $9.90 on Tuesday.
  • Analysts at Roth Capital initiated coverage on Cyclacel Pharmaceuticals Inc CYCC with a Buy rating. The price target for Cyclacel Pharmaceuticals is set to $8. Cyclacel Pharmaceuticals closed at $1.57 on Tuesday.
  • Analysts at Sandler O'Neill initiated coverage on Pacific City Financial Corp PCB with a Buy rating. The price target for Pacific City Financial is set to $23. Pacific City Financial closed at $20.70 on Tuesday.
Market News and Data brought to you by Benzinga APIs
Comments
Loading...
date
▲▼
ticker
▲▼
name
▲▼
Price Target
▲▼
Upside/Downside
▲▼
Recommendation
▲▼
Firm
▲▼
Posted In:
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!